stockrow
Friday 6 November 2026
Export RGC’s income statement to Excel — free account
Regencell Bioscience Holdings Limited
RGC Healthcare Drug Manufacturers Specialty & Generic
5.16
0.26
−4.80%
Follow RGC
Alert me
Regencell Bioscience Holdings Limited (RGC) Book value per share
Regencell Bioscience Holdings Limited's book value per share at the end of fiscal 2026 was 0.0×, up 175.5% from 0.0× in fiscal 2025. Over the past ten years it has ranged from 0.0× (fiscal 2021) to 0.0× (fiscal 2022); the current reading is higher than 88% of that period. Regencell Bioscience Holdings Limited ranks 58th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 0.0× | 175.51% |
| FY2025 | 0.0× | (40.96%) |
| FY2024 | 0.0× | (31.40%) |
| FY2023 | 0.0× | (31.05%) |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Jun 2025 | 0.0× | — |
| Jun 2024 | 0.0× | — |
| 8 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
88
Book value per share against peers
| Company | Book value per share |
|---|---|
| PBH Prestige Consumer Healthcare Inc. compare | 40.9× |
| PRGO Perrigo Company plc compare | 17.5× |
| TRLV Trulieve Cannabis Corp. compare | 4.0× |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 2.2× |
| XERS Xeris Biopharma Holdings, Inc. compare | 0.3× |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 0.0× |
| RGC Regencell Bioscience Holdings Limited | 0.0× |
| ALVO Alvotech compare | 0.0× |
| BCRX BioCryst Pharmaceuticals, Inc. compare | −1.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))